Aethlon Medical, Inc. (AEMD)

USD 0.35

(0.83%)

Market Cap (In USD)

7.29 Million

Revenue (In USD)

-

Net Income (In USD)

-12.2 Million

Avg. Volume

481.55 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.24-2.35
PE
-0.23
EPS
-1.52
Beta Value
1.755
ISIN
US00808Y4061
CUSIP
00808Y307
CIK
882291
Shares
20657100.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. James B. Frakes M.B.A.
Employee Count
-
Website
https://www.aethlonmedical.com
Ipo Date
1999-03-04
Details
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.